BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Tactile Medical - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://tactilemedical.com
X-WR-CALDESC:Events for Tactile Medical
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230117
DTEND;VALUE=DATE:20230118
DTSTAMP:20260508T164429
CREATED:20221216T190201Z
LAST-MODIFIED:20250610T163643Z
UID:10250-1673913600-1673999999@tactilemedical.com
SUMMARY:Pelvic Cancer Diagnosis\, Treatment and Related Lymphedema Continuing Education Course
DESCRIPTION:12-1 pm ET | 8-9 pm ET \nJoin us for a live 1 hour webinar focused on pelvic cancers including diagnosis\, treatment\, and survivorship concerns including pelvic cancer-related lymphedema. \nOBJECTIVES:\nThe participant will be able to: \n\n– Explain how cancer treatment effects the anatomy and physiology of soft tissue\, lymphatics\, and function for survivors of pelvic cancers.\n– Explain the revised Starling Principle and the implications it has in the treatment of chronic edema.\n– Associate the unique presentation of lymphedema and clinical concerns pelvic cancer survivors face.\n– Describe how to assess impairments and lymphedema for pelvic cancer survivors.\n– Describe treatment options for pelvic cancer-related lymphedema.\n\nTactile Medical is offering a complimentary virtual course for one continuing education contact hour (.1 CE). There is no penalty for cancellation of registration. Please visit page registration to see list of approved states. \n12-1 pm ET Registration               8-9 pm ET Registration  \nPlease email medicaleducation@tactilemedical.com for additional information.
URL:https://tactilemedical.com/event/pelvic-cancer-diagnosis-treatment-and-related-lymphedema-continuing-education-course-2023/
CATEGORIES:Continuing Education
END:VEVENT
END:VCALENDAR